Investors who jumped on the Hims & Hers Health (NYSE: HIMS) bandwagon have experienced this pain first-hand. Shares of the health and wellness platform operator skyrocketed more than 670% between Jan.

Hims & Hers Health, Inc. stock faces volatility after an FDA halt on its GLP-1 drug. Click here to find out why HIMS stock is ...

The knockoff surge was led by Hims & Hers Health, the telehealth firm that began selling the drugs last spring.

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

Undergoing surgery for a torn ligament in his right thumb marks a significant moment not only for him personally but also for the team as they approach the critical playoff season. Understanding Hims' ...

More importantly, if Hims can make a comeback during the playoffs, it will inject fresh energy into the Bucks' roster and could be key to turning the tide in crucial games. Discussing Hims's role ...

Hims & Hers Health, Inc. (NYSE:HIMS) recently launched a weight-loss portfolio, which was met with huge success. The offerings, which include oral weight loss and compounded GLP-1 injections, not only ...

Additionally, the company is witnessing continued success in acquiring customers through more cost-effective channels as awareness of the Hims & Hers brands grows. On the fourth-quarterearnings ...

He completed a 14-question intake on Hims.com and received a bottle of finasteride pills days later. He never spoke to a doctor. Soon after taking the medicine, Millich said he felt strange symptoms.

Many treatments are available, and with the popularity of online and mail-order services in recent years, two leaders are BlueChew and Hims. Both companies offer different ED treatments and a ...